Targeted Therapy to Prevent Progression of Calcific Aortic Stenosis
- 7 September 2004
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 110 (10), 1180-1182
- https://doi.org/10.1161/01.cir.0000140722.85490.ea
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic StenosisCirculation, 2004
- Hemodynamic Effects of the Angiotensin-Converting Enzyme Inhibitor, Ramipril, in Patients with Mild to Moderate Aortic Stenosis and Preserved Left Ventricular FunctionJournal of Investigative Medicine, 2004
- Human Aortic Valve Calcification Is Associated With an Osteoblast PhenotypeCirculation, 2003
- Experimental aortic valve stenosis in rabbitsJournal of the American College of Cardiology, 2003
- Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human PlasmaCirculation, 2002
- HMG CoA reductase inhibitor (statin) and aortic valve calciumThe Lancet, 2002
- Progression of Aortic Valve CalcificationCirculation, 2001
- ACE inhibition in aortic stenosis: dangerous medicine or golden opportunity?Journal of Human Hypertension, 2001
- Clinical Factors Associated With Calcific Aortic Valve DiseaseJournal of the American College of Cardiology, 1997
- Apolipoproteins B, (a), and E Accumulate in the Morphologically Early Lesion of ‘Degenerative’ Valvular Aortic StenosisArteriosclerosis, Thrombosis, and Vascular Biology, 1996